Last updated on 18 Jun 2021
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2167873 filed on 19 Feb 2021
Correspondent
Maren C. Perry King & Spalding LLP
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2167873
19 Feb 2021
19 Feb 2031
WORD
21 Aug 2020
US
Status Date | Action Taken |
---|---|
18th Jun 2021 | International Registration in Australia Protected correspondence sent |
17th Jun 2021 | IP Right Registration Published |
17th Jun 2021 | Status change to Registered/Protected |
10th Apr 2021 | Application Accepted correspondence sent |
9th Apr 2021 | IP Right has been Examined |
9th Apr 2021 | IP Right Acceptance Published |
9th Apr 2021 | Status change to Accepted |
8th Apr 2021 | Awaiting examination |
8th Apr 2021 | Examination expedited |
1st Apr 2021 | IP Right Filed Published |